Esa denied as non-formulary by Humana?

Humana's specific coverage criteria for esa are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Issues Non-Formulary Denials for ESAs

Humana's drug formulary (its covered-drug list) assigns each medication to a tier and may restrict coverage to one or more preferred agents within a therapeutic class. ESAs — which include multiple brand and biosimilar products — are subject to this tiering. A non-formulary denial means the specific ESA product prescribed is not on Humana's formulary for the patient's plan, or is restricted to a non-preferred tier that requires additional authorization. In some cases, only one preferred ESA agent is covered and the prescriber ordered an alternative.

## Why This Denial Is Appealable

Non-formulary denials are appealable on two distinct grounds. First, a formulary exception can be granted if the patient has a medical reason why the preferred formulary agent is unsuitable — for example, a documented adverse reaction, a contraindication the prescriber has identified, or clinical evidence that the non-formulary agent is medically necessary for this specific patient. Second, if the plan's formulary itself was applied incorrectly, that is a procedural basis for appeal.

## Federal Appeal Framework

• Internal appeal: File within the deadline in the denial notice. Request both a formulary exception and, if applicable, a standard medical-necessity appeal in the same submission.
• External review (ACA §2719 / ERISA §503): After a final internal denial, you may escalate to an Independent Review Organization. File within roughly four months of the final denial — verify the exact deadline in your denial letter.
• Expedited track: Available when delay would seriously jeopardize health; ask for expedited internal and external review simultaneously.

## Concrete Appeal Steps

1. Pull Humana's current formulary for the patient's plan year from the Humana website or provider portal and confirm the preferred ESA agent(s) listed. 2. Determine whether the patient has ever tried the preferred agent and, if so, document the outcome. 3. Have the prescriber complete Humana's formulary-exception request form, attaching the medical-necessity letter. 4. Submit the internal appeal package. 5. If denied, escalate to external IRO review.

## Documentation to Gather

• Diagnosis and treatment context: Chart notes confirming the qualifying diagnosis and the clinical rationale for ESA therapy.
• Preferred-agent trial or contraindication: If the patient tried the formulary-preferred ESA and it failed or caused adverse effects, document dates, doses administered (from the pharmacy records), and the specific clinical outcome. If the prescriber believes the preferred agent is contraindicated, a detailed letter explaining the clinical basis is essential.
• Prescriber medical-necessity letter: Should explain why the non-formulary product — not merely any ESA — is necessary for this patient, citing the FDA-approved prescribing label and Humana's own exception criteria.
• Pharmacy records: Dispense history showing any prior ESA use.

## Criteria-Mapping Structure

Humana's formulary-exception policy lists the grounds on which an exception may be granted. Obtain that policy from the provider portal. Build a two-column table: left column = each exception criterion verbatim; right column = the specific chart evidence satisfying it. Submit this table as the cover sheet of the appeal.